| Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis T Kuhlmann, V Miron, Q Cuo, C Wegner, J Antel, W Brück Brain 131 (7), 1749-1758, 2008 | 644 | 2008 |
| On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation CB Terwee, FW Dekker, WM Wiersinga, MF Prummel, PMM Bossuyt Quality of life research 12 (4), 349-362, 2003 | 634 | 2003 |
| Cardiovascular and noncardiovascular mortality among patients starting dialysis DJ de Jager, DC Grootendorst, KJ Jager, PC van Dijk, LMJ Tomas, ... Jama 302 (16), 1782-1789, 2009 | 625 | 2009 |
| Risk of depression in patients with chronic obstructive pulmonary disease and its determinants JG Van Manen, PJE Bindels, FW Dekker, CJ IJzermans, JS Van der Zee, ... Thorax 57 (5), 412-416, 2002 | 592 | 2002 |
| Long-term risks for kidney donors G Mjøen, S Hallan, A Hartmann, A Foss, K Midtvedt, O Øyen, A Reisæter, ... Kidney international 86 (1), 162-167, 2014 | 554 | 2014 |
| Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey SI Hallan, K Dahl, CM Oien, DC Grootendorst, A Aasberg, J Holmen, ... Bmj 333 (7577), 1047, 2006 | 501 | 2006 |
| Predictors of the rate of decline of residual renal function in incident dialysis patients MAM Jansen, AAM Hart, JC Korevaar, FW Dekker, EW Boeschoten, ... Kidney international 62 (3), 1046-1053, 2002 | 487 | 2002 |
| Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size WM Michels, DC Grootendorst, M Verduijn, EG Elliott, FW Dekker, ... Clinical Journal of the American Society of Nephrology 5 (6), 1003-1009, 2010 | 482 | 2010 |
| Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment MP Merkus, KJ Jager, FW Dekker, EW Boeschoten, P Stevens, RT Krediet, ... American journal of kidney diseases 29 (4), 584-592, 1997 | 480 | 1997 |
| Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial JC Korevaar, GW Feith, FW Dekker, JG Van Manen, EW Boeschoten, ... Kidney international 64 (6), 2222-2228, 2003 | 399 | 2003 |
| Renal replacement therapy in Europe: the results of a collaborative effort by the ERA–EDTA registry and six national or regional registries PCW van Dijk, KJ Jager, F de Charro, F Collart, R Cornet, FW Dekker, ... Nephrology Dialysis Transplantation 16 (6), 1120-1129, 2001 | 360 | 2001 |
| When do we need competing risks methods for survival analysis in nephrology? M Noordzij, K Leffondré, KJ van Stralen, C Zoccali, FW Dekker, KJ Jager Nephrology Dialysis Transplantation 28 (11), 2670-2677, 2013 | 358 | 2013 |
| Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on … F Termorshuizen, FW Dekker, JG van Manen, JC Korevaar, ... Journal of the American Society of Nephrology 15 (4), 1061-1070, 2004 | 356 | 2004 |
| High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients N Voormolen, M Noordzij, DC Grootendorst, I Beetz, YW Sijpkens, ... Nephrology Dialysis Transplantation 22 (10), 2909-2916, 2007 | 351 | 2007 |
| The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study … F Termorshuizen, JC Korevaar, FW Dekker, JG van Manen, ... American journal of kidney diseases 41 (6), 1293-1302, 2003 | 344 | 2003 |
| Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990–1999 B Stengel, S Billon, PCW van Dijk, KJ Jager, FW Dekker, K Simpson, ... Nephrology Dialysis Transplantation 18 (9), 1824-1833, 2003 | 325 | 2003 |
| Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation AG van Wassenaer, JH Kok, JJM de Vijlder, JM Briët, BJ Smit, ... New England Journal of Medicine 336 (1), 21-26, 1997 | 325 | 1997 |
| The kidney disease outcomes quality initiative (K/DOQI) guideline for bone metabolism and disease in CKD: association with mortality in dialysis patients M Noordzij, JC Korevaar, EW Boeschoten, FW Dekker, WJ Bos, ... American journal of kidney diseases 46 (5), 925-932, 2005 | 317 | 2005 |
| Sample size calculations: basic principles and common pitfalls M Noordzij, G Tripepi, FW Dekker, C Zoccali, MW Tanck, KJ Jager Nephrology dialysis transplantation 25 (5), 1388-1393, 2010 | 316 | 2010 |
| Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the … F Termorshuizen, JC Korevaar, FW Dekker, JG van Manen, ... Journal of the American Society of Nephrology 14 (11), 2851-2860, 2003 | 305 | 2003 |
